Encephalomyelitis: Clinical Trials

4 trials for Encephalomyelitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4

Follow Encephalomyelitis: new trials by email Literature Review of Encephalomyelitis trials Research Report on Encephalomyelitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
Pregabalin, Independent walking training, Placebo - Chronic Fatigue Syndrome, COVID-19, Long Haul
Phase 2TerminatedNational Institute of Geriatrics, Rheumatology and Rehabilitation, Poland232023-10-242026-06-17
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
Etanercept - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 2TerminatedHaukeland University Hospital42012-10-012015-12-02
Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
Droxidopa - Chronic Fatigue Syndrome, Orthostatic Hypotension
Phase 2TerminatedChelsea Therapeutics32010-07-012014-06-09
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome
Rituximab - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 2TerminatedHaukeland University Hospital82010-06-012024-03-04

Narrower conditions

Fatigue Syndrome, Chronic (4)  ·  Hypotension, Orthostatic (1)  ·  Post-Acute COVID-19 Syndrome (1)

Broader conditions

Chronic Disease (4)  ·  Disease Attributes (4)  ·  Muscular Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Nervous System Diseases (4)  ·  Neuroinflammatory Diseases (4)  ·  Neuromuscular Diseases (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Autonomic Nervous System Diseases (1)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)

Interventions

3,4-dihydroxyphenylserine aldolase (1)  ·  Droxidopa (1)  ·  Etanercept (1)  ·  Pregabalin (1)  ·  Psychotherapy (1)  ·  Rituximab (1)  ·  Telerehabilitation (1)

Sponsors

Haukeland University Hospital (2)  ·  Chelsea Therapeutics (1)  ·  National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland (1)

Countries

Norway (2)  ·  Poland (1)  ·  United States (1)

Top investigators

Beata Tarnacka, Prof, Md, PhD (1)  ·  Charles W Lapp, M.D. (1)  ·  Olav Mella, PhD, MD (1)

Results publications

PMID 26132314